EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular mechanisms of cisplatin resistance in ovarian cancer

Chenying Jiang, Chenjun Shen, Maowei Ni, Lili Huang, Hongtao Hu, Qinhui Dai, Huajun Zhao, Zhihui Zhu

Genes & Diseases · 2024-11 · 11 (6) · 101063

DOI: 10.1016/j.gendis.2023.06.032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes & Diseases, 2024-11. Verfasst von Chenying Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer is one of the most common malignant tumors of the female reproductive system. The majority of patients with advanced ovarian cancer are mainly treated with cisplatin-based chemotherapy. As the most widely used first-line anti-neoplastic drug, cisplatin produces therapeutic effects through multiple mechanisms. However, during clinical treatment, cisplatin resistance has gradually emerged, representing a challenge for patient outcome improvement. The mechanism of cisplatin resistance, while known to be complex and involve many processes, remains unclear. We hope to provide a new direction for pre-clinical and clinical studies through this review on the mechanism of ovarian cancer cisplatin resistance and methods to overcome drug resistance.

Schlagwörter

Stichwörter der Autor:innen

CisplatinDrug resistanceMolecular mechanismsOvarian cancerTherapeutic strategies

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China.
  • The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310005, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Jiang, C., Shen, C., Ni, M., Huang, L., Hu, H., Dai, Q., Zhao, H., & Zhu, Z. (2024). Molecular mechanisms of cisplatin resistance in ovarian cancer. Genes & Diseases, 11(6), 101063. https://doi.org/10.1016/j.gendis.2023.06.032

Vancouver

Jiang C, Shen C, Ni M, Huang L, Hu H, Dai Q, et al. Molecular mechanisms of cisplatin resistance in ovarian cancer. Genes & Diseases. 2024;11(6):101063. doi:10.1016/j.gendis.2023.06.032

BibTeX
@article{Jiang2024,
  author = {Jiang, Chenying and Shen, Chenjun and Ni, Maowei and Huang, Lili and Hu, Hongtao and Dai, Qinhui and Zhao, Huajun and Zhu, Zhihui},
  title = {Molecular mechanisms of cisplatin resistance in ovarian cancer},
  journal = {Genes & Diseases},
  year = {2024},
  volume = {11},
  number = {6},
  pages = {101063},
  doi = {10.1016/j.gendis.2023.06.032}
}
Kostenlos starten →